Create a narrative

Moberg Pharma Community

OM:MOB Community

1 Narratives written by author
0 Comments on narratives written by author
7 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Norway Expansion And EU Approvals Will Strengthen Future Position

Key Takeaways Expansion in Norway and obtaining EU approvals bolster revenue potential and support Moberg Pharma's European growth strategy. Retaining full rights to MOB-015 improves margins and control over commercialization, with supply chain enhancements ensuring stable product availability.

SEK 11.00

FV

22.3% undervalued

142.24%

Revenue growth p.a.

0

0

1

1 day ago